Levels of soluble fas/APO‐1 /CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis

Arthritis & Rheumatism

Volumn 38, Issue 12, 1995, Pages 1735-1737

  Knipping, Eckart ^a   Krammer, Peter H ^a   Onel, Karen B ^b   Lehman, Thomas J A ^b   Mysler, Eduardo ^b   Elkon, Keith B ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD95; ARTHRITIS, JUVENILE RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

EID: 0029564297     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780381205     Document Type: Article

References (11)

1. Monoclonal antibody‐mediated tumor regression by apoptosis
2. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
3. Apoptosis in SLE: too little or too much
4. The APO‐1/Fas protein in human systemic lupus erythematosus
5. Protection from Fas‐mediated apoptosis by a soluble form of the Fas molecule
6. The 1982 revised criteria for the classification of systemic lupus erythematosus
7. Current proposed revision of JRA criteria
8. Derivation of the SLEDAI: a disease activity index for lupus patients
9. Identification of soluble APO‐1 in supernatants of human B and T cell lines and increased serum levels in B and T cell leukemias
10. Molecular cloning and expression of a receptor for human tumor necrosis factor
11. Autocrine T‐cell suicide mediated by APO‐1/(Fas/CD95)